DAFNA Capital Management, LLC, a Los Angeles based SEC registered investment adviser, was established in 1999.

DAFNA specializes in managing long/short portfolios of predominately publicly traded biotechnology and medical device companies and currently utilizes three different long/short investment strategies. DAFNA performs detailed fundamental analysis and disciplined risk management.